Scientific article
OA Policy
English

Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

Published inJournal of Antimicrobial Chemotherapy, vol. 70, no. 12, p. 3323-3331
Publication date2015
Abstract

The most recommended NRTI combinations as first-line antiretroviral treatment for HIV-1 infection in resource-rich settings are tenofovir/emtricitabine, abacavir/lamivudine, tenofovir/lamivudine and zidovudine/lamivudine. Efficacy studies of these combinations also considering pill numbers, dosing frequencies and ethnicities are rare.

Keywords
  • Adult
  • Antiretroviral Therapy
  • Highly Active/methods
  • Drug Resistance
  • Viral
  • Female
  • HIV Infections/drug therapy
  • HIV-1
  • Humans
  • Male
  • Middle Aged
  • Nucleosides/therapeutic use
  • Nucleotides/therapeutic use
  • Reverse Transcriptase Inhibitors/therapeutic use
  • Switzerland
  • Treatment Failure
Citation (ISO format)
YANG, Wan-Lin et al. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study. In: Journal of Antimicrobial Chemotherapy, 2015, vol. 70, n° 12, p. 3323–3331. doi: 10.1093/jac/dkv257
Main files (1)
Article (Published version)
Identifiers
Journal ISSN0305-7453
451views
216downloads

Technical informations

Creation04/09/2018 14:34:00
First validation04/09/2018 14:34:00
Update09/02/2026 15:32:38
Status update09/02/2026 15:32:38
Last indexation09/02/2026 15:37:08
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack